cyclohexanol has been researched along with olanzapine in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 10 (76.92) | 29.6817 |
2010's | 3 (23.08) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ansseau, M; Pitchot, W | 1 |
Arguisola, MS; Tavakoli, SA | 1 |
Bowers, L; Callaghan, P; Clark, N; Evers, C | 1 |
Grignon, S; Trottier, M | 1 |
Devarajan, S; Dursun, SM | 1 |
Sicot, R | 1 |
Briggs, SD; Case, M; Corya, SA; Sanger, TM; Tollefson, G; Williamson, D | 1 |
Deng, C; Han, M; Huang, XF; Weston-Green, K | 1 |
Bahk, WM; Chae, JH; Jun, TY; Jung, YE; Seo, HJ; Woo, YS | 1 |
Campbell, GM; Case, M; Corya, SA; Henley, DB; Osuntokun, O; Thase, ME; Trivedi, MH; Watson, SB | 1 |
Fisar, Z; Hroudová, J; Raboch, J | 1 |
Aarya, KR; Grover, S; Sharma, A | 1 |
Ferentinos, P; Gournellis, R; Michopoulos, I; Oulis, P | 1 |
2 trial(s) available for cyclohexanol and olanzapine
Article | Year |
---|---|
A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression.
Topics: Benzodiazepines; Brief Psychiatric Rating Scale; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Mass Screening; Middle Aged; Olanzapine; Prospective Studies; Remission Induction; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Refusal; Venlafaxine Hydrochloride | 2006 |
Effect of augmented atypical antipsychotics on weight change in patients with major depressive disorder in a naturalistic setting.
Topics: Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Cyclohexanols; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Olanzapine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Weight Gain | 2009 |
11 other study(ies) available for cyclohexanol and olanzapine
Article | Year |
---|---|
Addition of olanzapine for treatment-resistant depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Olanzapine; Pirenzepine; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Diabetic ketoacidosis in a patient treated with olanzapine, valproic acid, and venlafaxine.
Topics: Adult; Anticonvulsants; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Cyclohexanols; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Drug Interactions; Drug Therapy, Combination; Humans; Male; Obesity; Olanzapine; Pirenzepine; Risk Factors; Valproic Acid; Venlafaxine Hydrochloride | 2003 |
Comparisons of psychotropic drug prescribing patterns in acute psychiatric wards across Europe.
Topics: Adult; Benzodiazepines; Biperiden; Chlorpromazine; Clozapine; Cyclohexanols; Diazepam; Drug Administration Schedule; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization Review; Europe; Female; Humans; Male; Mood Disorders; Olanzapine; Pharmacoepidemiology; Practice Patterns, Physicians'; Psychiatric Department, Hospital; Psychotropic Drugs; Schizophrenia; Time Factors; Venlafaxine Hydrochloride | 2004 |
Capgras syndrome in the modern era: self misidentification on an ID picture.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Capgras Syndrome; Cyclohexanols; Drug Therapy, Combination; Female; Humans; Olanzapine; Recurrence; Schizophrenia; Self Concept; Social Identification; Venlafaxine Hydrochloride; Visual Perception | 2005 |
Olanzapine plus venlafaxine in treatment-resistant depression.
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Cyclohexanols; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Humans; Olanzapine; Venlafaxine Hydrochloride | 2005 |
[Love, humor and psychosis in an atypical depression].
Topics: Antidepressive Agents; Antipsychotic Agents; Azabicyclo Compounds; Benzodiazepines; Clonazepam; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Hypnotics and Sedatives; Love; Olanzapine; Piperazines; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Wit and Humor as Topic | 2005 |
The effects of antipsychotics on the density of cannabinoid receptors in the dorsal vagal complex of rats: implications for olanzapine-induced weight gain.
Topics: Animals; Antipsychotic Agents; Autoradiography; Benzodiazepines; Binding, Competitive; Cyclohexanols; Female; Immunosuppressive Agents; Medulla Oblongata; Olanzapine; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Tritium; Weight Gain | 2008 |
An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Nortriptyline; Olanzapine; Personality Inventory; Psychometrics; Randomized Controlled Trials as Topic; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
Topics: Affect; Amitriptyline; Animals; Antidepressive Agents; Antimanic Agents; Benzodiazepines; Cerebral Cortex; Citalopram; Clorgyline; Cocaine; Cyclohexanols; Desipramine; Fluoxetine; Imipramine; In Vitro Techniques; Iproniazid; Lithium; Mianserin; Mirtazapine; Mitochondria; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Morpholines; Olanzapine; Pargyline; Reboxetine; Swine; Thiazepines; Valproic Acid; Venlafaxine Hydrochloride | 2010 |
Use of electroconvulsive therapy in an adolescent with systemic lupus erythematosus for management of depression.
Topics: Adolescent; Alkylating Agents; Anti-Inflammatory Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Cyclohexanols; Cyclophosphamide; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Humans; Lupus Erythematosus, Systemic; Olanzapine; Prednisolone; Venlafaxine Hydrochloride | 2013 |
Restless legs syndrome associated with the combined use of quetiapine and venlafaxine.
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Cyclohexanols; Dibenzothiazepines; Drug Substitution; Drug Therapy, Combination; Female; Humans; Middle Aged; Olanzapine; Quetiapine Fumarate; Restless Legs Syndrome; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |